Please use this identifier to cite or link to this item:
https://dora.health.qld.gov.au/qldresearchjspui/handle/1/9350| Title: | VIM: the results of a phase 1/2 trial of bortezomib, idarubicin and melphalan in relapsed or refractory multiple myeloma | Authors: | K Boyd F Davies G Morgan Ann Bonner L Conneely M Kabir G Machell C Pawlyn R Saso L Smith E Strong M Kaiser |
Issue Date: | Apr-2020 | Journal: | British Journal of Haematology |
| Appears in Sites: | Publication workflow Queensland Health Publications |
Show full item record
Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.